| 2013-05 |
Effective treatment of aggressive B-cell lymphomas by downregulated NIK-induced noncanonical NF-kappa B pathway activation through inhibition of BAFF |
Journal of Clinical Oncology. 2013 May;31(15 Suppl.):Abstract number e13554. |
|
| 2013-05 |
KRAS mutation status-stratified randomized phase II trial of GEMOX with and without cetuximab in advanced biliary tract cancer (ABTC): The TCOG T1210 trial |
Journal of Clinical Oncology. 2013 May;31(15 Suppl.):Abstract number 4018. |
|
| 2013-05 |
Impact of virologic factors on recurrence-free survival in HBV-related hepatocellular carcinoma after surgical resection: Post hoc analysis from a prospective study with long-term follow-up |
Journal of Clinical Oncology. 2013 May;31(15 Suppl.):Abstract number e15032. |
|
| 2013-04-22 |
The epidemiology of neuroendocrine tumors in Taiwan: A nation-wide cancer registry-based study |
PLoS ONE. 2013 Apr 22;8(4):Article number e62487. |
 |
| 2013-04 |
Fatty acid synthase overexpression confers an independent prognosticator and associates with radiation resistance in nasopharyngeal carcinoma |
Tumor Biology. 2013 Apr;34(2):759-768. |
|
| 2013-04 |
SKP2 overexpression is associated with a poor prognosis of rectal cancer treated with chemoradiotherapy and represents a therapeutic target with high potential |
Tumor Biology. 2013 Apr;34(2):1107-1117. |
|
| 2013-03-12 |
A novel synthetic microtubule inhibitor, MPT0B214 exhibits antitumor activity in human tumor cells through mitochondria-dependent intrinsic pathway |
PLoS ONE. 2013 Mar 12;8(3):Article number e58953. |
|
| 2013-03 |
Auy922, a novel Hsp90 inhibitor effective against ABC-dlbcl and malt lymphoma cells harboring genetic alteration-associated NF-kappa B activation |
Annals of Oncology. 2013 Mar;24(Suppl. 1):24-25. |
|
| 2013-02 |
Autophagy is involved in endogenous and NVP-AUY922-induced KIT degradation in gastrointestinal stromal tumors |
Autophagy. 2013 Feb;9(2):220-233. |
|
| 2013-01 |
Randomised clinical trial: Comparison of two everolimus dosing schedules in patients with advanced hepatocellular carcinoma |
Alimentary Pharmacology and Therapeutics. 2013 Jan;37(1):62-73. |
|
| 2012-12-21 |
HuR cytoplasmic expression is associated with increased cyclin A expression and poor outcome with upper urinary tract urothelial carcinoma |
BMC Cancer. 2012 Dec 21;12:Article number 611. |
|
| 2012-11 |
Potential role of KLF10 in the regulation of gemcitabine resistance in pancreatic cancer cells |
Pancreatology. 2012 Nov;12(6):510-511. |
|
| 2012-11 |
Blockage of Nrf2/AKR1C axis enhanced therapeutic efficacy of oxaliplatin in oxaliplatin resistant gastric cancer cells |
European Journal of Cancer. 2012 Nov;48(Suppl. 6):48. |
|
| 2012-10 |
Front-line antibiotic therapy in early-stage H. Pylori-positive gastric Diffuse Large B-Cell Lymphomas with or without malt features |
Annals of Oncology. 2012 Oct;23(Suppl. 11):105. |
|
| 2012-09 |
Rsf-1/HBXAP overexpression is independent of gene amplification and is associated with poor outcome in patients with urinary bladder urothelial carcinoma |
Journal of Clinical Pathology. 2012 Sep;65(9):802-807. |
|
| 2012-09 |
Digestive cancer management in Asia: Position statements: A report on GI oncology summit in 2011 |
Journal of Gastroenterology and Hepatology. 2012 Sep;27(9):1417-1422. |
|
| 2012-09 |
Heat shock protein 90 inhibition downregulates c-Kit expression in gist cells through diminishing transcription and enhancing protein degradation via both autophagy and proteasome pathways |
Annals of Oncology. 2012 Sep;23(Suppl. 9):538. |
|
| 2012-09 |
Detection of caga expression in gastric mucosa-associated lymphoid tissue lymphoma-biologic significance and clinical implication |
Annals of Oncology. 2012 Sep;23(Suppl. 9):351. |
|
| 2012-08 |
Rsf-1 expression in rectal cancer: With special emphasis on the independent prognostic value after neoadjuvant chemoradiation |
Journal of Clinical Pathology. 2012 Aug;65(8):687-692. |
|
| 2012-08 |
Contribution of blocked potassium current conductance and increased conductance of persistent sodium current to the afterdischarge in myelinated neuron |
Muscle and Nerve. 2012 Aug;46(2):297-299. |
|
| 2012-07 |
Promoter methylation of argininosuccinate synthetase-1 sensitises lymphomas to arginine deiminase treatment, autophagy and caspase-dependent apoptosis |
Cell Death and Disease. 2012 Jul;3:Article number e342. |
|
| 2012-06-15 |
Targeted Casp8AP2 methylation increases drug resistance in mesenchymal stem cells and cancer cells |
Biochemical and Biophysical Research Communications. 2012 Jun 15;422(4):578-585. |
|
| 2012-05-24 |
Helicobacter pylori eradication therapy is effective in the treatment of early-stage H pylori-positive gastric diffuse large B-cell lymphomas |
Blood. 2012 May 24;119(21):4838-4844. |
|
| 2012-05-20 |
Randomized phase II trial of TACE plus everolimus as first-line therapy in localized unresectable hepatocellular carcinoma (HCC): The TRACER trial |
Journal of Clinical Oncology. 2012 May 20;30(15 Suppl.):Abstract number TPS4149. |
|
| 2012-04 |
Alpha-methylacyl coenzyme A racemase overexpression in gallbladder carcinoma confers an independent prognostic indicator |
Journal of Clinical Pathology. 2012 Apr;65(4):309-314. |
|
| 2012-03 |
Involvement of autophagy in endogenous and NVP-AUY922-induced C-kit degradation in both imatinib-sensitive and -resistant gastrointestinal stromal tumor cells |
Annals of Oncology. 2012 Mar;23(Suppl. 1):28. |
|
| 2012-02 |
Phase II study of concomitant thalidomide during radiotherapy for hepatocellular carcinoma |
International Journal of Radiation Oncology, Biology, Physics. 2012 Feb;82(2):817-825. |
|
| 2012-02 |
EGFR nuclear import in gallbladder carcinoma: Nuclear phosphorylated EGFR upregulates iNOS expression and confers independent prognostic impact |
Annals of Surgical Oncology. 2012 Feb;19(2):443-454. |
|
| 2012-02 |
Phase I study of biweekly liposome irinotecan (PEP02, MM-398) in metastatic colorectal cancer failed on firstline oxaliplatin-based chemotherapy |
Journal of Clinical Oncology. 2012 Feb;30(4):613. |
|
| 2012-01 |
Long-term results of a randomized, observation-controlled, phase III trial of adjuvant Interferon alfa-2b in hepatocellular carcinoma after curative resection |
Annals of Surgery. 2012 Jan;255(1):8-17. |
|
| 2011-12-15 |
Combination of arsenic trioxide and BCNU synergistically triggers redox-mediated autophagic cell death in human solid tumors |
Free Radical Biology and Medicine. 2011 Dec 15;51(12):2195-2209. |
|
| 2011-12 |
Induction chemotherapy with gemcitabine, oxaliplatin, and 5-Fluorouracil/Leucovorin followed by concomitant chemoradiotherapy in patients with locally advanced pancreatic cancer: A Taiwan cooperative oncology group phase II study |
International Journal of Radiation Oncology, Biology, Physics. 2011 Dec;81(5):e749-e757. |
|
| 2011-12 |
t(11;18)(q21;q21) translocation as predictive marker for non-responsiveness to salvage thalidomide therapy in patients with marginal zone B-cell lymphoma with gastric involvement |
Cancer Chemotherapy and Pharmacology. 2011 Dec;68(6):1387-1395. |
|
| 2011-11 |
Establishment of a novel MALT lymphoma cell line, ma-1, from a patient with t(14;18)(q32;q21)-positive Helicobacter Pylori-independent gastric MALT lymphoma |
Genes Chromosomes and Cancer. 2011 Nov;50(11):908-921. |
|
| 2011-11 |
Role of chromogranin a and neuron-specific enolase biomarkers in progression-free survival (PFS) with everolimus (EVE) versus placebo (PB) in patients with advanced pancreatic neuroendocrine tumors (pNET): Phase III radiant-3 results |
Neuroendocrinology. 2011 Nov;94(Suppl. 1):37. |
|
| 2011-10-01 |
Enhancement of non-homologous end joining DNA repair capacity confers cancer cells resistance to the novel selenophene compound, D-501036 |
Cancer Letters. 2011 Oct 1;309(1):110-118. |
|
| 2011-09 |
B cell-activating factor of TNF family (BAFF) signaling pathway is associated with Helicobacter Pylori-independent growth of gastric MALT lymphoma without T(11;18)(q21;q21) |
European Journal of Cancer. 2011 Sep;47(Suppl 1):S648-S649. |
|
| 2011-09 |
Phase II study of low-dose everolimus plus weekly cisplatin and 24-hour infusion of high-dose 5-fluorouracil and leucovorin for first-line treatment of metastatic or recurrent gastric cancers |
European Journal of Cancer. 2011 Sep;47(Suppl 1):S467. |
|
| 2011-09 |
Nanovector-based therapies in advanced pancreatic cancer |
Journal of Gastrointestinal Oncology. 2011 Sep;2(3):185-194. |
|
| 2011-08-17 |
A phase II and pharmacokinetic study of first line S-1 for advanced gastric cancer in Taiwan |
Cancer Chemotherapy and Pharmacology. 2011 Aug 17;67(6):1281-1289. |
|
| 2011-08 |
Identification of salt-inducible kinase 3 as a novel tumor antigen associated with tumorigenesis of ovarian cancer |
Oncogene. 2011 Aug;30(33):3570-3584. |
|
| 2011-07 |
Pharmacoeconomic analysis of capecitabine versus 5-fluorouracil/leucovorin as adjuvant therapy for stage III colon cancer in Taiwan |
Value in Health. 2011 Jul;14(5):647-651. |
|
| 2011-05 |
Lack of compensatory pAKT activation and eIF4E phosphorylation of lymphoma cells towards mTOR inhibitor, RAD001 |
European Journal of Cancer. 2011 May;47(8):1244-1257. |
|
| 2011-05 |
Novel Hsp90 inhibitor NVP-AUY922 downregulates mutant c-Kit protein through transcription and enhancing protein degradation via both proteasome and autophagy-mediated pathways |
Drug Metabolism Reviews. 2011 May;43(Suppl. 1):78-79. |
|
| 2011-04 |
Activation of Akt/FoxO axis confers resistance to cisplatin in human nasopharyngeal carcinomas |
Cancer Research. 2011 Apr;71:Abstract number 1701. |
|
| 2011-03-07 |
2-Amino-3,4,5-Trimethoxybenzophenones as Potent Tubulin Polymerization Inhibitors |
ChemMedChem. 2011 Mar 7;6(3):450-456. |
|
| 2011-02 |
Loss of ASS1 expression in myxofibrosarcoma via promoter hypermethylation: Prognostic and potential therapeutic implications |
Laboratory Investigation. 2011 Feb;91:17A. |
|
| 2011-02 |
Loss of ASS1 expression in myxofibrosarcoma via promoter hypermethylation: Prognostic and potential therapeutic implications |
Modern Pathology. 2011 Feb;24(Suppl. 1):17A-18A. |
|
| 2011-02 |
Effect of inhibition of heat-shock protein 90 on mutant c-Kit protein as modulated by mRNA expression and protein degradation through both proteasome and autophagy-mediated pathways |
Journal of Clinical Oncology. 2011 Feb;29(Suppl. 4):Abstract Number 54 |
|
| 2011-02 |
A multinational phase II study of liposome irinotecan (PEP02) for patients with gemcitabine-refractory metastatic pancreatic cancer |
Journal of Clinical Oncology. 2011 Feb;29(4):Abstract Number 237. |
|
